| Financier | Commitments |
|---|---|
| Trust Funds | 1.20 |
| IDA Credit | 20.98 |
| IDA Grant | 20.98 |
Niger COVID-19 Emergency Response Project
Abstract*
The Niger proposed project is aligned to the country COVID-19 preparedness and response plan that amounts to US$175 million, out of which the World Bank is financing US$13.9 million. The World Bank support will focus on strategic activities that will provide a platform for all donors and interventions. The World Bank’s support will aim to align the many actors responding to the COVID-19 pandemic in Niger to promote synergies, complementarity and efficiency... Show More
Development Objective
To prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness in Niger
Key Details
Project Details
P173846
Closed
Mohamed Taleb El Hassen , Paul Robyn
Republic of Niger,Ministry of Planning
April 3, 2020
(as of board presentation)
April 13, 2020
July 8, 2020
US$ 43.15 million
Ministry of Public Health, Population and Social Affairs
2020
US$ 43.15 million
N/A
Substantial
December 31, 2024
No
BANK APPROVED
January 19, 2024
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | N/A |
| IDA Commitment | 41.95 |
| IBRD + IDA Commitment | 41.95 |
| Lending Instrument | |
|---|---|
| Grant Amount | 1.20 |
| Total Project Cost** | 43.15 |
Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| May 3, 2024 | IDA-69570 | Int Charges | 193.13 |
| May 3, 2024 | IDA-69570 | Int Charges | 193.13 |
| Apr 30, 2024 | IDA-69570 | Int Charges | 1,323.18 |
| Apr 30, 2024 | IDA-69570 | Int Charges | 1,323.18 |
| Apr 30, 2024 | IDA-69570 | Int Charges | 15,285.77 |
| Apr 30, 2024 | IDA-69570 | Int Charges | 15,285.77 |
| May 31, 2024 | IDA-69570 | Loan Disb | 1,281,135.00 |
| Aug 2, 2024 | IDA-66200 | Loan Disb | -133,052.34 |
| Aug 27, 2024 | IDA-66200 | Loan Disb | 1,058,233.40 |
| Jun 21, 2023 | IDA-66200 | Loan Disb | 135,907.05 |
| Apr 17, 2023 | IDA-69570 | Int Charges | 18,741.69 |
| Apr 17, 2023 | IDA-69570 | Int Charges | 18,741.69 |
| Apr 12, 2023 | IDA-69570 | Loan Disb | 1,130,109.10 |
| Jan 25, 2023 | IDA-69570 | Loan Disb | 4,729.60 |
| May 15, 2023 | IDA-66200 | Int Charges | 10,093.85 |
| May 15, 2023 | IDA-66200 | Int Charges | 10,093.85 |
| May 15, 2023 | IDA-69570 | Loan Disb | 502,200.38 |
| Nov 15, 2022 | IDA-66200 | Int Charges | 9,366.00 |
| Nov 15, 2022 | IDA-66200 | Int Charges | 9,366.00 |
| Dec 23, 2022 | IDA-69570 | Loan Disb | 7,857,455.50 |
| Jun 20, 2022 | IDA-E1040 | Loan Commitment | 13,350,000.00 |
| Jun 20, 2022 | IDA-71880 | Loan Commitment | 13,350,000.00 |
| Jun 25, 2021 | IDA-69570 | Loan Commitment | 14,000,000.00 |
| Jun 25, 2021 | IDA-D8700 | Loan Commitment | 14,000,000.00 |
| Apr 13, 2020 | IDA-66200 | Loan Commitment | 6,975,000.00 |
| Apr 13, 2020 | IDA-D6180 | Loan Commitment | 6,975,000.00 |
| Dec 13, 2022 | IDA-D8700 | Loan Disb | 570,732.20 |
| Dec 20, 2022 | IDA-D8700 | Loan Disb | 11,524,263.00 |
| Jun 24, 2022 | IDA-D8700 | Loan Disb | 802,722.80 |
| Jan 27, 2021 | IDA-D6180 | Loan Disb | 174,177.60 |
| Oct 5, 2020 | IDA-D6180 | Loan Disb | 594,698.40 |
| Mar 2, 2021 | IDA-D6180 | Loan Disb | 202,376.00 |
| Mar 4, 2021 | IDA-D6180 | Loan Disb | 99,000.00 |
| Mar 18, 2021 | IDA-D6180 | Loan Disb | 345,373.97 |
| Jan 15, 2021 | IDA-D6180 | Loan Disb | 732,603.75 |
| Dec 28, 2020 | IDA-D6180 | Loan Disb | 1,387,629.50 |
| Mar 11, 2021 | IDA-D6180 | Loan Disb | 259,082.36 |
| Oct 1, 2022 | IDA-69570 | Int Charges | 970.32 |
| Oct 1, 2022 | IDA-69570 | Int Charges | 970.32 |
| May 15, 2022 | IDA-66200 | Int Charges | 7,692.31 |
| May 15, 2022 | IDA-66200 | Int Charges | 7,692.31 |
| Jun 29, 2022 | IDA-69570 | Loan Disb | 545,647.10 |
| Jun 29, 2022 | IDA-66200 | Loan Disb | 324,208.38 |
| Jan 26, 2022 | IDA-66200 | Loan Disb | 546,957.30 |
| Aug 3, 2021 | IDA-66200 | Loan Disb | 468,057.88 |
| Nov 15, 2021 | IDA-66200 | Int Charges | 4,813.52 |
| Nov 15, 2021 | IDA-66200 | Int Charges | 4,813.52 |
| Nov 15, 2021 | IDA-66200 | Int Charges | 143.32 |
| Nov 15, 2021 | IDA-66200 | Int Charges | 143.32 |
| Apr 12, 2021 | IDA-66200 | Loan Disb | 204,511.58 |
| Jun 10, 2021 | IDA-66200 | Loan Disb | 194,134.27 |
| Jun 10, 2021 | IDA-66200 | Loan Disb | 102,065.13 |
| Jul 26, 2021 | IDA-66200 | Loan Disb | 440,667.80 |
| Aug 3, 2021 | IDA-66200 | Loan Disb | 571,254.25 |
| Apr 26, 2021 | IDA-66200 | Loan Disb | 21,690.45 |
| Aug 19, 2020 | IDA-D6180 | Loan Disb | 3,620,696.00 |
| Jun 25, 2024 | IDA-69570 | Loan Disb | 166,898.33 |
| Apr 30, 2024 | IDA-69570 | Int Charges | 37,905.61 |
| Apr 30, 2024 | IDA-69570 | Int Charges | 37,905.61 |
| May 29, 2024 | IDA-66200 | Int Charges | 10,569.99 |
| May 29, 2024 | IDA-66200 | Int Charges | 10,569.99 |
| Apr 30, 2024 | IDA-66200 | Int Charges | 10,353.88 |
| Apr 30, 2024 | IDA-69570 | Int Charges | 20,395.54 |
| Apr 30, 2024 | IDA-69570 | Int Charges | 20,395.54 |
| Apr 30, 2024 | IDA-66200 | Int Charges | 10,353.88 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Overall Implementation Progress (IP) | Satisfactory | 2025-04-01 |
| Procurement | Satisfactory | 2025-04-01 |
| Progress towards achievement of PDO | Satisfactory | 2025-04-01 |
| Project Management | Satisfactory | 2025-04-01 |
| Financial Management | Satisfactory | 2025-04-01 |
| Monitoring and Evaluation | Satisfactory | 2025-04-01 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Efficiency of a public health coordination mechanism for COVID-19 Value No Yes Yes Date March 24, 2020 February 22, 2024 December 31, 2024 Comment Suspected cases of COVID-19 cases reported and investigated based on national guidelines Value 0.00 99.81 100.00 Date March 24, 2020 February 22, 2024 June 30, 2023 Comment Laboratories with trained staff and consumables for collecting COVID-19 samples and transporting to the National Public Health Llaboratory (Centre de Recherche Médicale et Sanitaire, CERMES) Value 0.00 17.00 20.00 Date March 24, 2020 February 22, 2024 December 31, 2024 Comment Targeted regions with pandemic preparedness and response plans per Ministry of Public Health Guidelines Value 0.00 100.00 100.00 Date March 24, 2020 February 22, 2024 December 31, 2024 Comment Population vaccinated, which is included in the priority population targets defined in national plan Value 0.00 20.00 15.00 Date March 12, 2021 February 22, 2024 December 31, 2024 Comment Population vaccinated, which is included in the priority population targets defined in national plan - Female Value 0.00 8.14 6.00 Date June 11, 2021 February 22, 2024 December 31, 2024 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Country has developed a communication and risk communication plan including community engagement strategies Value No Yes Yes Date March 24, 2020 February 22, 2024 December 31, 2024 Comment M&E system established and implemented to monitor project progress Value No Yes Yes Date March 24, 2020 February 22, 2024 December 31, 2024 Comment Personal protective equipment (PPE) kits delivered to health facilities Value 0.00 50000.00 12000.00 Date March 24, 2020 February 22, 2024 December 31, 2024 Comment Radio Stations broadcast COVID-19 risk communication message Value 0.00 12.00 90.00 Date March 24, 2020 February 22, 2024 December 31, 2024 Comment Number of healthcare professionals and district investigation officers trained on detection and reporting, or investigation of AEFIs Value 0.00 0.00 200.00 Date March 29, 2022 February 22, 2024 December 31, 2024 Comment Health staff trained in infection prevention per MOH-approved protocols Value 0.00 300.00 600.00 Date March 24, 2020 February 22, 2024 December 31, 2024 Comment Gender sensitive educational materials on COVID-19 vaccines distributed Value No Yes Yes Date May 7, 2021 February 22, 2024 December 31, 2024 Comment Laboratories with trained staff and consumables for collecting COVID-19 samples and transporting to National Public Health laboratory Value 0.00 17.00 12.00 Date March 24, 2020 February 22, 2024 December 31, 2024 Comment Healthcare professionals and district investigation officers trained on detection and reporting, or investigation of AEFIs- Female Value 0.00 0.00 100.00 Date May 17, 2022 February 22, 2024 December 31, 2024 Comment Grievances received and addressed within the defined timeframe Value 0.00 100.00 90.00 Date June 11, 2021 February 22, 2024 December 31, 2024 Comment Targeted healthcare facilities with clinical capacity for COVID-19 patients Value 0.00 56.00 62.00 Date March 24, 2020 February 22, 2024 December 31, 2024 Comment Doses of eligible COVID-19 vaccines delivered in-country Value 0.00 0.00 2000000.00 Date June 11, 2021 February 22, 2024 December 31, 2024 Comment People trained on the installation, monitoring and maintenance of the cold chain equipment Value 0.00 0.00 200.00 Date March 12, 2021 February 22, 2024 December 31, 2024 Comment Women trained on the installation, monitoring and maintenance of the cold chain equipment-Female Value 0.00 0.00 100.00 Date June 11, 2021 February 22, 2024 December 31, 2024 Comment Expansion of functioning cold chain equipment and stored vaccines Value 0.00 100.00 150.00 Date March 12, 2021 February 22, 2024 December 31, 2024 Comment Expansion of functioning cold chain equipment and stored vaccines in rural, nomadic and desert areas- nomadic and desert areas Value 0.00 65.00 60.00 Date June 4, 2021 February 22, 2024 December 31, 2024 Comment Oxygen plant installed and functional Value 0.00 1.00 3.00 Date March 29, 2022 February 22, 2024 December 31, 2024 Comment Female vaccinator present in Vaccination centers Value 0.00 42.80 50.00 Date March 15, 2022 February 22, 2024 December 31, 2024 Comment